Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus with reduced calcineurin inhibitor regimen in ABO incompatible kidney transplantation
KCT0005271Phase 4Not yet recruiting
- Sponsor
- Asan Medical Center
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sirolimus, sponsored by Asan Medical Center. Planned start Jul 2020; status: not yet recruiting.
02
Drugs
sirolimus
Beyond the preview
Go deeper on KCT0005271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0005271.